PDCD1 and neoplasm: Moreover, a growing body of evidence has shown that several immune-related ceRNAs are present in the tumor microenvironment (TME), and they significantly influence immune cell infiltration and cancer-cell response to anti-PD-1 immunotherapy in different cancers [21].